A case of reactivation of varicella-zoster virus after BNT162b2 vaccine second dose?

Authors :: Santovito LS
Pinna G
Source :: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2021 Sep; Vol. 70 (9), pp. 935-937. Date of Electronic Publication: 2021 Aug 14.
Publication Year :: 2021
Abstract: We report a case of itchy papulovesicular rash consistent with varicella-zoster virus reactivation after Pfizer-BioNTech vaccine second dose administration. While there have been cases of varicella-zoster virus reactivation due to COVID-19 or COVID-19 vaccine inoculation in older individuals with pre-existing conditions, this case report describes the first case of varicella-zoster virus reactivation on a healthy, young male in the absence of pre-existing conditions. The mechanisms underlying varicella-zoster virus reactivation in patients with COVID-19 are unknown and should be further characterized.<br /> (© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)

Subjects :: Adult
BNT162 Vaccine
COVID-19 Vaccines administration & dosage
Chickenpox pathology
Humans
Male
Skin pathology
Vaccination adverse effects
COVID-19 Vaccines adverse effects
Chickenpox etiology
Chickenpox virology
Herpesvirus 3, Human

Language :: English
ISSN :: 1420-908X
Volume :: 70
Issue :: 9
Database :: MEDLINE
Journal :: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Publication Type :: Academic Journal
Accession number :: 34390376
Full Text :: https://doi.org/10.1007/s00011-021-01491-w

Full Text Access

Tools